Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

LACTULOSE

All products: general benefit

Other products in the same Health Canada class (A06A) — coverage varies; not interchangeable

  • Prucalopride (Resotran): not a benefit

Pharma-Lactulose · DIN 02247383 · 667mg/mL · oral liquid

General benefitDormant since 2026-07-31 · checked 2026-09-19 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Pharma-Lactulose · DIN 02247383 Manufacturer: Pharmascience Inc.; listing date 2013-06-27 Health Canada: Dormant since 2026-07-31 · brand PHARMA-LACTULOSE · ATC A06AD11 LACTULOSE · form Solution · route Oral · ingredients LACTULOSE 667 MG/ML · company Pharmascience inc · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Pharma-Lactulose: Formulary list price $0.0145/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0145 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71628 · Verify on the e-Formulary ↗ (DIN 02247383)

Source record
DIN 02247383: Pharma-Lactulose Raw flags: sec3=Y Item: 564000004; group id 679; item number 1695; lccId None; manufacturer id PMS Source form: O/L; strength: 667mg/mL Recorded listing: General benefit Source prices (unrounded): $0.0145; ministry $0.0145 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02247383 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71628
Interchangeable products
Apo-Lactulose Solution · DIN 02242814 · $0.0145 Cephulac · DIN 02091925 · not recorded Jamp-Lactulose · DIN 02295881 · $0.0145 Lactulose · DIN 02412268 · $0.0145 PMS-Lactulose-Pharma · DIN 02469391 · $0.0145 Ratio-Lactulose · DIN 00854409 · $0.0145
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Dormant since 2026-07-31 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (56:40 Miscellaneous G.I. Drugs) and how they are covered

Matched class: 56:40 Miscellaneous G.I. Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BUDESONIDE, MESALAZINE, NIZATIDINE, OLSALAZINE SODIUM, PANTOPRAZOLE MAGNESIUM, RABEPRAZOLE SODIUM, SUCRALFATE Some products covered without a code (check the product listing): 5-AMINOSALICYLIC ACID, CIMETIDINE, DOMPERIDONE MALEATE, FAMOTIDINE, METOCLOPRAMIDE HCL, MISOPROSTOL, RANITIDINE HCL 56:40 Miscellaneous G.I. Drugs

PRUCALOPRIDE

· 10 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1mg, 2mg · Tab

5-AMINOSALICYLIC ACID

· 17 products · General benefit (16), Listed, not a benefit (1) · strengths: 1g/Actuation, 500mg, 1.2g, 1g, 1g/100mL, 4g/100mL, 4g, 1000mg, 400mg · 14 Actuation-Foam Enema Canister Pk, Del-Release Tab, Delayed & ER Tab, DR Tab, Enema, Ent Tab, ER Tab, Rect Susp-Pk, Sup, Tab

BUDESONIDE

· 1 products · General benefit · strengths: 2mg/Act · Rectal Foam-14 Act Canister

CIMETIDINE

· 10 products · General benefit (5), Listed, not a benefit (5) · strengths: 200mg, 300mg, 400mg, 600mg, 800mg · Tab

DOMPERIDONE MALEATE

· 11 products · Listed, not a benefit (1), General benefit (10) · strengths: 10mg · Tab

FAMOTIDINE

· 16 products · Listed, not a benefit (2), General benefit (14) · strengths: 20mg, 40mg · Tab

MESALAZINE

· 2 products · General benefit · strengths: 800mg, 1600mg · DR Tab

METOCLOPRAMIDE HCL

· 8 products · Limited Use, codes 481, 657 (2), Listed, not a benefit (2), General benefit (4) · strengths: 5mg/mL, 5mg, 10mg · Inj Sol (Preservative Free), Tab

MISOPROSTOL

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 100mcg, 200mcg · Tab

NIZATIDINE

· 2 products · General benefit · strengths: 150mg, 300mg · Cap

OLSALAZINE SODIUM

· 1 products · General benefit · strengths: 250mg · Cap

PANTOPRAZOLE MAGNESIUM

· 6 products · General benefit · strengths: 40mg · Ent Coated Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 56:40 and 10 more
Full class listing Related classes: 56:04 Antacids and Adsorbents, 56:08 Antidiarrhea Agents, 56:12 Cathartics, 56:16 Digestants, 56:22 Antiemetics and Antinauseants Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no link
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)